GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $40,000 | +60.0% | 1,000 | +60.0% | 0.09% | +45.0% |
| Q2 2018 | $25,000 | -26.5% | 625 | -28.6% | 0.06% | -33.3% |
| Q1 2018 | $34,000 | +25.9% | 875 | +16.7% | 0.09% | +40.6% |
| Q4 2017 | $27,000 | -55.0% | 750 | -49.3% | 0.06% | -39.6% |
| Q3 2017 | $60,000 | -9.1% | 1,480 | -2.6% | 0.11% | 0.0% |
| Q2 2017 | $66,000 | +3.1% | 1,520 | 0.0% | 0.11% | +16.5% |
| Q1 2017 | $64,000 | +8.5% | 1,520 | 0.0% | 0.09% | -7.1% |
| Q4 2016 | $59,000 | +11.3% | 1,520 | +23.1% | 0.10% | +5.4% |
| Q3 2016 | $53,000 | -17.2% | 1,235 | -16.8% | 0.09% | -8.8% |
| Q2 2016 | $64,000 | +12.3% | 1,485 | +6.1% | 0.10% | +20.0% |
| Q1 2016 | $57,000 | +23.9% | 1,400 | +21.7% | 0.08% | +30.8% |
| Q4 2015 | $46,000 | +4.5% | 1,150 | 0.0% | 0.06% | +4.8% |
| Q3 2015 | $44,000 | +18.9% | 1,150 | +30.7% | 0.06% | +44.2% |
| Q2 2015 | $37,000 | -5.1% | 880 | +3.5% | 0.04% | -8.5% |
| Q1 2015 | $39,000 | 0.0% | 850 | -7.1% | 0.05% | +4.4% |
| Q4 2014 | $39,000 | +62.5% | 915 | +77.7% | 0.04% | +45.2% |
| Q3 2014 | $24,000 | +84.6% | 515 | +106.0% | 0.03% | +40.9% |
| Q1 2014 | $13,000 | – | 250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KAHN BROTHERS GROUP INC | 1,282,289 | $46,483,403 | 7.25% |
| Columbia Asset Management | 9,960 | $361 | 0.08% |
| PARK CIRCLE Co | 800 | $29,000 | 0.03% |
| PARADIGM ASSET MANAGEMENT CO LLC | 1,800 | $65,250 | 0.02% |
| Byrne Asset Management LLC | 56 | $2,000 | 0.00% |
| Retirement Group, LLC | 40 | $1,450 | 0.00% |
| Bartlett & Co. LLC | 240 | $9 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $40 | 0.00% |